Training courses & Webinars:
Biopharma

“Excellent. Really enjoyed and learned a lot.”

Anthony Barker, Director - Regulatory CMC, Home Address

“I gained much more understanding than what I had intended to. The trainer also involved everybody in the course and did not make it boring. The topics of non-clinical, clinical, strategy as well as market entry/IP etc were covered briefly too. So that was an added advantage.”

Anjali Apte, Manager, Regulatory Affairs, PharmaLex UK Services Ltd

“Fully satisfied; even this was managed online, it was great.”

, , Zentiva Group, a.s.

“Really interesting, and a great introduction to someone with little/no knowledge of biotechnology. Also great that it went from scientific processes through to industrial processes. Nicely laid out. Well worth the three days!”

Jackie Knipe, IP Paralegal, ALBUMEDIX LTD

“I felt like the three days flowed together really well, first giving a basic understanding of the biology side of these products, how they are made and then their uses. ”

Laura Jones, Regulatory CMC Manager, AstraZeneca

“The presentations were well prepared in general and I learned a lot.”

Katja Pecjak, Director of Regulatory Affairs & QPPV, Billev farmacija vzhod d.o.o

“Globally good presentation, speaker tried to make people participate which is difficult by webinar.”

Frédéric LALLEMAND, Consultant, Lallemand Conseil

“I thought it was a really interesting overview of biotechnology, from the specific scientific processes all the way through to the industry trends. I appreciated the discussion of advantages/ disadvantages and challenges of various methods and the industry as a whole, as I think this added a lot of context. This was beneficial for me when I was trying to apply what I had learned in the day to my specific company's context.”

Sian Gilfillan, Marketing and Communications Associate, Albumedix

“The course was comprehensive and the speakers were both subject matter experts and very good presenters. I really enjoyed the three days.”

Linnea Elrington, VP, Head of HR, Silence Therapeutics

“A good general introduction that managed to make this very technical subject matter understandable to those with little scientific background, or as a refresher to those who may have graduated many years previously.”

Matthew Jordan, , Imerys Minerals